| Microtubules and resistance to tubulin-binding agents M Kavallaris Nature Reviews Cancer 10 (3), 194-204, 2010 | 1127 | 2010 |
| Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. M Kavallaris, DY Kuo, CA Burkhart, DL Regl, MD Norris, M Haber, ... The Journal of clinical investigation 100 (5), 1282-1293, 1997 | 756 | 1997 |
| Metronomic chemotherapy: new rationale for new directions E Pasquier, M Kavallaris, N André Nature reviews Clinical oncology 7 (8), 455-465, 2010 | 672 | 2010 |
| Movers and shakers: cell cytoskeleton in cancer metastasis CM Fife, JA McCarroll, M Kavallaris British journal of pharmacology 171 (24), 5507-5523, 2014 | 470 | 2014 |
| Minimum information reporting in bio–nano experimental literature M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ... Nature nanotechnology 13 (9), 777-785, 2018 | 445 | 2018 |
| Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells KM Murphy, V Ranganathan, ML Farnsworth, M Kavallaris, RB Lock Cell Death & Differentiation 7 (1), 102-111, 2000 | 396 | 2000 |
| Microtubules and their role in cellular stress in cancer AL Parker, M Kavallaris, JA McCarroll Frontiers in oncology 4, 153, 2014 | 365 | 2014 |
| Biologically targeted magnetic hyperthermia: Potential and limitations D Chang, M Lim, JACM Goos, R Qiao, YY Ng, FM Mansfeld, M Jackson, ... Frontiers in pharmacology 9, 831, 2018 | 345 | 2018 |
| Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non–small cell lung cancer PP Gan, E Pasquier, M Kavallaris Cancer research 67 (19), 9356-9363, 2007 | 301 | 2007 |
| The role of beta-tubulin isotypes in resistance to antimitotic drugs. CA Burkhart, M Kavallaris Biochimica et biophysica acta 1471 (2), O1-9, 2001 | 288 | 2001 |
| Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells M Kavallaris, AS Tait, BJ Walsh, L He, SB Horwitz, MD Norris, M Haber Cancer research 61 (15), 5803-5809, 2001 | 281 | 2001 |
| Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol M Kavallaris, CA Burkhart, SB Horwitz British journal of cancer 80 (7), 1020-1025, 1999 | 255 | 1999 |
| Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment E Pasquier, J Ciccolini, M Carre, S Giacometti, R Fanciullino, C Pouchy, ... Oncotarget 2 (10), 797, 2011 | 238 | 2011 |
| Microtubules: a dynamic target in cancer therapy E Pasquier, M Kavallaris IUBMB life 60 (3), 165-170, 2008 | 237 | 2008 |
| Acid-labile core cross-linked micelles for pH-triggered release of antitumor drugs Y Chan, T Wong, F Byrne, M Kavallaris, V Bulmus Biomacromolecules 9 (7), 1826-1836, 2008 | 213 | 2008 |
| Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood R Tavallaie, J McCarroll, M Le Grand, N Ariotti, W Schuhmann, E Bakker, ... Nature nanotechnology 13 (11), 1066-1071, 2018 | 207 | 2018 |
| Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β‐tubulins S Tommasi, A Mangia, R Lacalamita, A Bellizzi, V Fedele, A Chiriatti, ... International journal of cancer 120 (10), 2078-2085, 2007 | 204 | 2007 |
| Role of pancreatic stellate cells in chemoresistance in pancreatic cancer JA McCarroll, S Naim, G Sharbeen, N Russia, J Lee, M Kavallaris, ... Frontiers in physiology 5, 141, 2014 | 177 | 2014 |
| Anticancer therapy with novel tubulin-interacting drugs M Kavallaris, NM Verrills, BT Hill Drug Resistance Updates 4 (6), 392-401, 2001 | 165 | 2001 |
| Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release JS Basuki, HTT Duong, A Macmillan, RB Erlich, L Esser, MC Akerfeldt, ... ACS nano 7 (11), 10175-10189, 2013 | 163 | 2013 |
